Loading…

A CD44-biosensor for evaluating metastatic potential of breast cancer cells based on quartz crystal microbalance

A sensitive CD44-biosensor based on quartz crystal microbalance (QCM) was proposed for evaluating metastatic potential of breast cancer cells by using hyaluronan (HA) functionalized substrate film, poly- dopamine and polyethyleneimine composite film, for the purpose of capturing CD44-positive cancer...

Full description

Saved in:
Bibliographic Details
Published in:Science bulletin (Beijing) 2017-07, Vol.62 (13), p.923-930
Main Authors: Yang, Xiaojuan, Zhou, Rongcheng, Hao, Yan, Yang, Peihui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A sensitive CD44-biosensor based on quartz crystal microbalance (QCM) was proposed for evaluating metastatic potential of breast cancer cells by using hyaluronan (HA) functionalized substrate film, poly- dopamine and polyethyleneimine composite film, for the purpose of capturing CD44-positive cancer cells through specific binding of HA to CD44. Two differently CD44-expressed breast cancer cell lines (MDA- MB-231 cells and MCF-7 cells) were put to use as targets for quantitative analysis as well as evaluation of metastatic potential of the cells. The limit of detection for MDA-MB-231 (M231) cells and MCF-7 cells were 300 and 1,000 cells mL 1 respectively. The expression level of CD44 on M231 cells exhibited two times higher than that of MCF-7 cells, indicating of a higher metastatic potential. Moreover, poly-L- lysine modified QCM sensor was applied to monitor the stiffness of breast cancer cells that can reflect metastatic potential of cells. The results revealed that the MCF-7 cells were stiffer than M231 cells, imply- ing that the M231 cells possessed higher metastatic potential. The proposed protocol is simple and rapid to evaluate the metastatic potential of cancer cells, in addition to offering a promising diagnostic tool for metastatic cancer.
ISSN:2095-9273
DOI:10.1016/j.scib.2017.05.022